Search research articles
Contact Us
Filters
Showing results (711-720 of 870) with videos related to
Page
of 87
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
March 6, 2004
Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404
Michael D Prados, Wendy Seiferheld, Howard M Sandler, et al.
Brachytherapy
|
April 28, 2015
Combination therapy improves prostate cancer survival for patients with potentially lethal prostate cancer: The impact of Gleason pattern 5
Adam L Liss, Eyad I Abu-Isa, Maha S Jawad, et al.
Radiology
|
February 1, 1994
Cardiovascular/interventional radiology
D L Miller, J F Cardella, J J Cronan, et al.
JAMA Network Open
|
November 1, 2023
Mortality Risk for Docetaxel-Treated, High-Grade Prostate Cancer With Low PSA Levels: A Meta-Analysis
Brandon A Mahal, Lucia Kwak, Wanling Xie, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 7, 2021
Drivers of Medicare Spending: A 15-Year Review of Radiation Oncology Charges Allowed by the Medicare Physician/Supplier Fee-for-Service Program Compared With Other Specialties
Meriem Mokhtech, James H Laird, Sean Maroongroge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2007
Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02
Li Yan Khor, Jennifer Moughan, Tahseen Al-Saleem, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 22, 2007
Positional stability of electromagnetic transponders used for prostate localization and continuous, real-time tracking
Dale W Litzenberg, Twyla R Willoughby, James M Balter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2008
Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer
Eric M Horwitz, Kyounghwa Bae, Gerald E Hanks, et al.
Emergency Radiology
|
September 1, 2005
Acute non-traumatic maternal illnesses in pregnancy: imaging approaches
Saween K S Thompson, Stanford M Goldman, Komal B Shah, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 18, 2004
Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV
Jeff M Michalski, K Winter, James A Purdy, et al.
Page
of 87
Search research articles
Search
Showing results (711-720 of 870) with videos related to
Sort By:
Page
of 87
International Journal of Radiation Oncology, Biology, Physics
|
March 6, 2004
Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404
Michael D Prados, Wendy Seiferheld, Howard M Sandler, et al.
Brachytherapy
|
April 28, 2015
Combination therapy improves prostate cancer survival for patients with potentially lethal prostate cancer: The impact of Gleason pattern 5
Adam L Liss, Eyad I Abu-Isa, Maha S Jawad, et al.
Radiology
|
February 1, 1994
Cardiovascular/interventional radiology
D L Miller, J F Cardella, J J Cronan, et al.
JAMA Network Open
|
November 1, 2023
Mortality Risk for Docetaxel-Treated, High-Grade Prostate Cancer With Low PSA Levels: A Meta-Analysis
Brandon A Mahal, Lucia Kwak, Wanling Xie, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 7, 2021
Drivers of Medicare Spending: A 15-Year Review of Radiation Oncology Charges Allowed by the Medicare Physician/Supplier Fee-for-Service Program Compared With Other Specialties
Meriem Mokhtech, James H Laird, Sean Maroongroge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2007
Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02
Li Yan Khor, Jennifer Moughan, Tahseen Al-Saleem, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 22, 2007
Positional stability of electromagnetic transponders used for prostate localization and continuous, real-time tracking
Dale W Litzenberg, Twyla R Willoughby, James M Balter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2008
Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer
Eric M Horwitz, Kyounghwa Bae, Gerald E Hanks, et al.
Emergency Radiology
|
September 1, 2005
Acute non-traumatic maternal illnesses in pregnancy: imaging approaches
Saween K S Thompson, Stanford M Goldman, Komal B Shah, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 18, 2004
Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV
Jeff M Michalski, K Winter, James A Purdy, et al.
Page
of 87